LH/Mav |
urine sodium excretion rate to body weight ratio |
controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
84 days
| 12 |
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
0.0 |
|
0 |
|
|
103463 |
2825 |
LH/Mav |
urine sodium excretion rate to body weight ratio |
controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
147 days-154 days |
6 |
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
0.0 |
|
0 |
|
|
103466 |
2825 |
LH/Mav |
urine sodium excretion rate to body weight ratio |
controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
147 days-154 days |
6 |
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
0.0 |
|
0 |
|
|
103467 |
2825 |
BN/NHsdMcwi |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.44 |
mmol/l/100g |
0.03 |
0.09 |
flame photometry |
0.0 |
|
0 |
|
. |
102060 |
2645 |
BN/NHsdMcwi |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.21 |
null |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
na/k |
102064 |
2645 |
LH-Chr 13BN/Mav |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.11 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102066 |
2645 |
LH/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
0.52 |
null |
0.03 |
0.09 |
flame photometry |
0.0 |
|
0 |
|
|
102069 |
2645 |
MW |
urine sodium excretion rate |
sham surgical control condition (for 28 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
urine sodium amount |
male |
0 days
| 7 |
1.28 |
mEq/d |
0.07 |
0.19 |
flame photometry |
0.0 |
sham surgery |
28 |
days |
|
101047 |
2561 |
SHRSP/A3N |
net sodium influx to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
sodium ion homeostasis trait |
both |
180 days-270 days |
15 |
8.24 |
mmol/kg/h |
3.8 |
14.72 |
flame photometry |
0.0 |
|
0 |
|
|
107641 |
3094 |
WKY/N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
180 days-270 days |
9 |
7.38 |
mmol/kg/h |
2.3 |
6.9 |
flame photometry |
0.0 |
|
0 |
|
|
107642 |
3094 |
SHRSP/A3N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
141 days
| 7 |
12.3 |
mmol/kg/h |
1.4 |
3.7 |
flame photometry |
0.0 |
|
0 |
|
|
107644 |
3094 |
LH-Chr 13BN/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
0.52 |
null |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
. |
102070 |
2645 |
BN-Chr 13LH/MavRrrc |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 9 |
1.95 |
mmol/l/100g |
0.09 |
0.27 |
flame photometry |
0.0 |
|
0 |
|
|
102059 |
2645 |
LH/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.45 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
|
102061 |
2645 |
LH/Mav |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.12 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102065 |
2645 |
BN-Chr 13LH/MavRrrc |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 9 |
0.21 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102067 |
2645 |
MW |
urine sodium excretion rate |
nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
urine sodium amount |
male |
0 days
| 7 |
1.5 |
mEq/d |
0.15 |
0.4 |
flame photometry |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101049 |
2561 |
MW |
urine sodium excretion rate |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
urine sodium amount |
male |
0 days
| 7 |
1.78 |
mEq/d |
0.28 |
0.74 |
flame photometry |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101050 |
2561 |
LH-Chr 13BN/Mav |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.42 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
|
102054 |
2645 |
BN/NHsdMcwi |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
0.56 |
null |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
na/k |
102068 |
2645 |
BN/NHsdMcwi |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.2 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
. |
102072 |
2645 |
LH-Chr 13BN/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.12 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102074 |
2645 |
BN/NHsdMcwi |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.49 |
mmol/l/100g |
0.04 |
0.13 |
flame photometry |
0.0 |
|
0 |
|
. |
102052 |
2645 |
LH-Chr 13BN/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
2.0 |
mmol/l/100g |
0.08 |
0.25 |
flame photometry |
0.0 |
|
0 |
|
. |
102058 |
2645 |
SHRSP/A3N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
180 days-270 days |
15 |
14.69 |
mmol/kg/h |
7.7 |
29.82 |
flame photometry |
0.0 |
|
0 |
|
|
107643 |
3094 |
LH-Chr 13BN/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.43 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
|
102062 |
2645 |
BN-Chr 13LH/MavRrrc |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 9 |
0.64 |
null |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
|
102071 |
2645 |
BN-Chr 13LH/MavRrrc |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 9 |
0.21 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102075 |
2645 |
BN/NHsdMcwi |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
1.32 |
mmol/l/100g |
0.09 |
0.28 |
flame photometry |
0.0 |
|
0 |
|
. |
102056 |
2645 |
LH/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161 days
| 10 |
2.76 |
mmol/l/100g |
0.24 |
0.76 |
flame photometry |
0.0 |
|
0 |
|
|
102057 |
2645 |
SHRSP/A3N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
controlled hydralazine content drinking water (100 mg/l) (for 60 days) and controlled hydrochlorothiazide content drinking water (100 mg/l) (for 60 days) then controlled hydralazine content drinking water (200 mg/l) (for 60 days) and controlled hydrochlorothiazide content drinking water (200 mg/l) (for 60 days) |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
141 days
| 6 |
12.2 |
mmol/kg/h |
1.2 |
2.94 |
flame photometry |
0.0 |
|
0 |
|
|
107645 |
3094 |
WKY/N |
net sodium influx to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
sodium ion homeostasis trait |
both |
180 days-270 days |
11 |
5.12 |
mmol/kg/h |
2.6 |
8.62 |
flame photometry |
0.0 |
|
0 |
|
|
107640 |
3094 |
BN-Chr 13LH/MavRrrc |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 9 |
0.65 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
0.0 |
|
0 |
|
|
102055 |
2645 |
MW |
urine sodium excretion rate |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
urine sodium amount |
male |
0 days
| 7 |
1.39 |
mEq/d |
0.15 |
0.4 |
flame photometry |
0.0 |
5/6 nephrectomy |
28 |
days |
|
101048 |
2561 |
BN-Chr 13LH/MavRrrc |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 9 |
0.61 |
mmol/l/100g |
0.03 |
0.09 |
flame photometry |
0.0 |
|
0 |
|
|
102063 |
2645 |
LH/Mav |
urine sodium excretion rate to body weight ratio |
control condition (for 84 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
84 days
| 12 |
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
0.0 |
|
0 |
|
|
103460 |
2825 |
LH/Mav |
urine sodium excretion rate to body weight ratio |
controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
84 days
| 13 |
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
0.0 |
|
0 |
|
|
103462 |
2825 |
LH/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175 days
| 10 |
0.1 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
0 |
|
|
102073 |
2645 |
LH/Mav |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133 days
| 10 |
0.49 |
mmol/l/100g |
0.04 |
0.13 |
flame photometry |
0.0 |
|
0 |
|
|
102053 |
2645 |